弥合差距:分析乳腺成像报告和数据系统 (BI-RADS) 0 在不成比例地受影响的社区中的率和相关风险因素
Mona P Roshan1, Rebecca O'Connell2, Maheen Nazarally2
1Radiology, Florida International University, Herbert Wertheim College of Medicine, Miami, USA.
Cureus
|July 2, 2024
概括
在Linda Fenner 3D移动乳房扫描中心选的无保险妇女中,观察到高比例的不确定的乳房扫描 (BI-RADS 0). 年龄较小,更年期前的状态和先前的良性活检增加了不确定的结果,而肥胖却减少了这些结果.
科学领域:
- 放射学 放射学是一门学科.
- 在瘤学瘤学.
- 公共卫生 公共卫生
背景情况:
- 乳腺癌查获取的差异导致了在迈阿密-戴德的不保险妇女的琳达·芬纳3D移动乳房摄影中心 (LFMMC).
- 鉴定出了大量的不确的乳房造影 (BI-RADS 0),造成了进一步手术和患者痛苦的风险.
研究的目的:
- 调查使用LFMMC的无保险妇女的非确性查乳房镜 (BI-RADS 0) 的频率和风险因素.
主要方法:
- 一项回顾性横截面研究分析了3044名40岁以上的无保险妇女的数据,这些妇女以前没有乳腺癌史.
- 评估了人口因素,病史 (包括BMI,激素治疗,良性活检,家族病史) 和更年期状态.
- 多变量后勤回归确定了BI-RADS 0结果的预测因素.
主要成果:
- 在研究人群中,BI-RADS 0的总体频率为35% (平均年龄51岁).
- BI-RADS 0 的更高几率与年轻的年龄,单身婚姻状况,绝经前状态和良性活检史有关.
- 肥胖和乳腺植入史与BI-RADS 0.0的几率下降有关.
结论:
- 在LFMMC的样本中,高频率的乳房镜检查结果不确定 (BI-RADS 0).
- 潜在的促成因素包括高风险患者群体或年轻的人口查.
- 建议进行进一步的研究,以了解BI-RADS 0的放射科医生决策,并探索年轻女性的替代查.
更多相关视频
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Relative Risk
149
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
149
Statistical Methods for Analyzing Epidemiological Data
349
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
349
Comparing the Survival Analysis of Two or More Groups
176
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
176
Biological Effects of Radiation
15.4K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
15.4K
Cancer Survival Analysis
342
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
342


